Price
Financials
Standalone, Rs crore| Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.04 | 0.01 | 0.01 | 0.02 | 0.04 | 0.01 | 0.01 | 0.02 | 0.04 | 0.01 | 0.02 | 0.08 |
| Operating Profit | -0.04 | -0.01 | -0.01 | -0.02 | -0.04 | -0.01 | -0.01 | -0.02 | -0.04 | -0.01 | -0.02 | -0.08 |
| OPM % | ||||||||||||
| Other Income | 0.00 | 0.00 | 0.00 | -1.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -5.44 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.04 | -0.01 | -0.01 | -1.19 | -0.04 | -0.01 | -0.01 | -0.02 | -0.04 | -0.01 | -5.46 | -0.08 |
| Tax % | 0.00% | 0.00% | 0.00% | 6.72% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.04 | -0.01 | -0.01 | -1.27 | -0.04 | -0.01 | -0.01 | -0.02 | -0.04 | -0.01 | -5.46 | -0.08 |
| EPS in Rs | -0.08 | -0.02 | -0.02 | -2.44 | -0.08 | -0.02 | -0.02 | -0.04 | -0.08 | -0.02 | -10.48 | -0.15 |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 38.37 | 10.69 | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 38.34 | 10.89 | 0.44 | 0.02 | 0.02 | 0.03 | 0.04 | 0.07 | 0.05 | 0.06 | 0.08 | 0.15 |
| Operating Profit | 0.03 | -0.20 | -0.03 | -0.02 | -0.02 | -0.03 | -0.04 | -0.07 | -0.05 | -0.06 | -0.08 | -0.15 |
| OPM % | 0.08% | -1.87% | -7.32% | |||||||||
| Other Income | 0.00 | 0.00 | -0.31 | -0.02 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | -1.17 | 0.00 | -5.44 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.02 | -0.21 | -0.35 | -0.05 | -0.03 | -0.03 | 0.00 | -0.07 | -0.06 | -1.23 | -0.08 | -5.59 |
| Tax % | 0.00% | 0.00% | -20.00% | 40.00% | 66.67% | 66.67% | 0.00% | 0.00% | 6.50% | 0.00% | 0.00% | |
| Net Profit | 0.02 | -0.21 | -0.28 | -0.07 | -0.05 | -0.04 | -0.02 | -0.07 | -0.06 | -1.31 | -0.08 | -5.59 |
| EPS in Rs | 0.04 | -0.40 | -0.54 | -0.13 | -0.10 | -0.08 | -0.04 | -0.13 | -0.12 | -2.51 | -0.15 | -10.73 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | % | ||
| Compounded Profit Growth | 3% | % | % | -75% | ||
| Stock Price CAGR | -4% | -4% | % | % | ||
| Return on Equity | -1% | -2% | -3% | -4% |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 |
| Reserves | 3.06 | 2.85 | 2.57 | 2.50 | 2.45 | 2.35 | 2.33 | 2.25 | 2.20 | 0.88 | 0.80 | -4.79 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 |
| Other Liabilities | 10.24 | 0.31 | 0.85 | 0.63 | 0.48 | 0.09 | 0.56 | 0.54 | 0.51 | 0.64 | 0.60 | 0.20 |
| Total Liabilities | 18.51 | 8.37 | 8.63 | 8.34 | 8.14 | 7.65 | 8.10 | 8.00 | 7.92 | 6.73 | 6.76 | 0.62 |
| Fixed Assets | 0.11 | 0.10 | 0.09 | 0.08 | 0.07 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.18 | 1.21 | 1.20 | 1.17 | 1.17 | 1.18 | 1.18 | 1.18 | 1.32 | 0.15 | 0.15 | 0.00 |
| Other Assets | 17.22 | 7.06 | 7.34 | 7.09 | 6.90 | 6.46 | 6.92 | 6.82 | 6.60 | 6.58 | 6.61 | 0.62 |
| Total Assets | 18.51 | 8.37 | 8.63 | 8.34 | 8.14 | 7.65 | 8.10 | 8.00 | 7.92 | 6.73 | 6.76 | 0.62 |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0.04 | 0.02 | -0.02 | -0.01 | 0.00 | 0.00 | -0.12 | 1.57 | 0.13 | 0.01 | 0.66 | 0.62 |
| Cash from Investing Activity | 0.03 | -0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.57 | -0.12 | -0.02 | -0.66 | 0.00 |
| Cash from Financing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | -0.15 |
| Net Cash Flow | -0.01 | -0.02 | -0.02 | -0.01 | 0.00 | 0.00 | -0.02 | 0.00 | 0.01 | -0.01 | 0.00 | 0.47 |
| Free Cash Flow | -0.04 | 0.02 | -0.02 | -0.01 | 0.00 | 0.00 | -0.12 | 1.57 | 0.13 | 0.01 | 0.66 | 0.62 |
| CFO/OP | -133% | -10% | 67% | 50% | 0% | 0% | 300% | -2,243% | -260% | -17% | -825% | -413% |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 128.90 | 120.19 | 3,988.29 | |||||||||
| Inventory Days | 4.70 | 14.00 | 0.00 | |||||||||
| Days Payable | 97.26 | 2.05 | ||||||||||
| Cash Conversion Cycle | 36.33 | 132.14 | 3,988.29 | |||||||||
| Working Capital Days | 62.50 | 131.80 | 3,436.34 | |||||||||
| ROCE % | 0.24% | -2.57% | -0.51% | -0.39% | -0.39% | -0.39% | 0.00% | -0.93% | -0.67% | -0.89% | -1.31% | -4.26% |
| Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 12.48% | 12.48% | 12.48% | 12.48% | 12.48% | 12.48% | 12.48% | 12.48% | 12.48% | 12.48% | 12.48% | 12.48% |
| Public | 87.52% | 87.52% | 87.52% | 87.52% | 87.52% | 87.52% | 87.52% | 87.52% | 87.52% | 87.52% | 87.52% | 87.52% |
| No. of Shareholders | 1,199 | 1,189 | 1,188 | 1,188 | 1,188 | 1,187 | 1,188 | 1,193 | 1,194 | 1,193 | 1,196 | 1,207 |
Fundamentals
Market Cap₹ 1.67 Cr.
Current Price₹ 3.20
Book Value₹ 0.81
ROCE-4.26 %
ROE-4.35 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)%
Compounded Profit Growth (TTM)-75%
Standalone figures.
Valuation
P/B, 3-year average0.29x
P/B, 5-year average0.25x
Profitability
ROE-173.87%
ROCE-169.91%
ROA-151.49%
ROE, 3-year average-64.87%
ROCE, 3-year average-63.15%
ROA, 3-year average-56.85%
ROE, 5-year average-39.27%
ROCE, 5-year average-38.21%
ROA, 5-year average-34.44%
Other income / net worth-1295.24%
Per share
EPS (TTM)Rs -10.71
EPS (latest quarter)Rs -0.15
EPS, 3-year averageRs -1.33
EPS, 5-year averageRs -0.73
Book value per shareRs 0.80
Cash flow per shareRs 1.19
Free cash flow per shareRs 1.19
Efficiency
Creditor days2 days
Cash conversion cycle3988 days
Working capital days3436 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Owners' fund to total sources67.74%
Cash flow
Cash from Operating Activity (latest year)Rs 1 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs 1 Cr
Statement figures
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs -5 Cr
EBITDA (TTM)Rs -6 Cr
PBDT (TTM)Rs -6 Cr
Profit before tax (TTM)Rs -6 Cr
Net profit (TTM)Rs -6 Cr
Net profit (latest year)Rs -6 Cr
Net profit (latest quarter)Rs -0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total income (latest year)Rs -5 Cr
Share capitalRs 5 Cr
ReservesRs -5 Cr
Shareholders' fundsRs 0 Cr
Total assetsRs 1 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)0.52
Ownership
Promoter holding12.48% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 3.97 is at the 85th percentile (median 0.28).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Not enough price history.
Red flags
F-score 4 of 6| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2021Sales ₹0 Cr.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Trans Asia Corporation Ltd(Liquidated)?
Trans Asia Corporation Ltd(Liquidated) (530783) has a market capitalisation of Rs 1.67 Cr. at the close.
What were Trans Asia Corporation Ltd(Liquidated)'s latest quarterly results?
In the Mar 2021 quarter, Trans Asia Corporation Ltd(Liquidated) sales was Rs 0 Cr with a net loss of Rs 0 Cr.